Ileana Aderca

发表

Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas

David I. Smith, Xiangyang Dong, D. Nagorney, 2002, Oncogene.

Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4‐associated cholangitis from cholangiocarcinoma

T. Therneau, N. Takahashi, C. Moser, 2011, Hepatology.

Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter.

D. Tindall, E. Galanis, S. Russell, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients

L. Roberts, I. Aderca, Teresa A. Mettler, 2006, Journal of Cancer Research and Clinical Oncology.

Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy

E. Thompson, J. Sarkaria, A. Oberg, 2018, Journal of the National Cancer Institute.

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.

L. Hartmann, J. Sloan, J. Sloan, 2010, Cancer research.

Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival

Thomas D. Schmittgen, Y. Gusev, Jinmai Jiang, 2008, Clinical Cancer Research.

The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX.

S. Thibodeau, J. Cunningham, C. Moser, 2008, Journal of hepatology.

Oncolytic measles virus strains have significant antitumor activity against glioma stem cells

J. Sarkaria, E. Galanis, M. Opyrchal, 2012, Gene Therapy.

Effective radiovirotherapy for malignant gliomas by using oncolytic measles virus strains encoding the sodium iodide symporter (MV-NIS).

J. Sarkaria, E. Galanis, M. Opyrchal, 2012, Human gene therapy.

Measles Edmonston Vaccine Strain Derivatives have Potent Oncolytic Activity against Osteosarcoma

E. Galanis, Aditya Bansal, T. DeGrado, 2014, Cancer Gene Therapy.

Phase I clinical trial of locoregional administration of the oncolytic adenovirus ONYX-015 in combination with mitomycin-C, doxorubicin, and cisplatin chemotherapy in patients with advanced sarcomas.

E. Galanis, M. Opyrchal, I. Aderca, 2009, Methods in molecular biology.

Sulfatase 2 up‐regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma

S. Thorgeirsson, T. Han, Ju-Seog Lee, 2008, Hepatology.

hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling.

David I. Smith, J. Cunningham, J. Chien, 2004, Gastroenterology.

Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers

B. McMahon, E. Thorland, J. Bruix, 2003, Oncogene.

Methylated Bone Morphogenetic Protein 3 (BMP3) Gene: Evaluation of Tumor Suppressor Function and Biomarker Potential in Biliary Cancer

D. Ahlquist, C. Moser, L. Roberts, 2013, Journal of molecular biomarkers & diagnosis.

SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma.

Chunrong Yu, T. Han, C. Moser, 2006, Gastroenterology.

The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3–dependent Wnt activation

T. Han, S. Sanderson, C. Moser, 2010, Hepatology.

The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.

T. Therneau, G. Gores, J. Bida, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Restoration of Epigenetically Silenced Sulfatase 1 Expression by 5-Aza-2′-Deoxycytidine Sensitizes Hepatocellular Carcinoma Cells to Chemotherapy-Induced Apoptosis

C. Moser, L. Roberts, N. Tsuchiya, 2015, Medical Epigenetics.

Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy

Asha A. Nair, Minetta C. Liu, J. Ingle, 2015, Cancer Gene Therapy.

Sulfatase 2 up‐regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma

S. Thorgeirsson, T. Han, Ju-Seog Lee, 2008, Hepatology.

Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors

S. Sanderson, C. Moser, L. Roberts, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer.

A. Oberg, L. Hartmann, E. Galanis, 2015, Cancer research.

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.

L. Hartmann, J. Sloan, E. Galanis, 2010, Cancer research.

The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX.

S. Thibodeau, J. Cunningham, C. Moser, 2008, Journal of hepatology.

The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3–dependent Wnt activation

Sherine F. Elsawa, T. Han, S. Sanderson, 2010, Hepatology.

Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy

Asha A. Nair, J. Ingle, E. Galanis, 2015, Cancer Gene Therapy.